David Gildea1,2. 1. UCL Institute of Ophthalmology, 11-43 Bath St, London, EC1V 9EL, UK. gildead@tcd.ie. 2. Mater Misericordiae University Hospital, Dublin, Republic of Ireland. gildead@tcd.ie.
Abstract
PURPOSE: Diabetic retinopathy (DR) is one of the leading causes of blindness worldwide. Accurate investigative tools are essential for the early diagnosis and monitoring of the disease. Optical coherence tomography angiography (OCTA) is a recently developed technology that enables visualisation of the retinal microvasculature. METHODS: A systematic review of the literature was performed to examine the diagnostic use of OCTA in DR to date. Medline, EMBASE, and Cochrane databases were searched to find relevant studies. Sixty-one original studies were selected for the review. RESULTS AND DISCUSSION: OCTA has demonstrated the ability to identify microvascular features of DR such as microaneurysms, neovascularisation, and capillary non-perfusion. Furthermore, OCTA is enabling quantitative evaluation of the microvasculature of diabetic eyes. It has demonstrated the ability to detect early microvascular changes, in eyes with or without clinically evident DR. It has also been shown to detect progressive changes in the foveal avascular zone, and vascular perfusion density, with worsening severity of disease. It provides three-dimensional visualisation of the individual retinal vascular networks and is thereby enhancing our understanding of the role of the deeper vasculature in the pathogenesis of diabetic retinopathy and maculopathy. CONCLUSION: However, limitations exist with current OCTA technology, in respect to the small field of view, image quality, projection artefact, and inaccuracies in analysis of the deeper vascular layers. While questions remain regarding its practical applicability in its present form, with continuing development and improvement of the technology, the diagnostic value of OCTA in diabetic retinopathy is likely to become evident.
PURPOSE:Diabetic retinopathy (DR) is one of the leading causes of blindness worldwide. Accurate investigative tools are essential for the early diagnosis and monitoring of the disease. Optical coherence tomography angiography (OCTA) is a recently developed technology that enables visualisation of the retinal microvasculature. METHODS: A systematic review of the literature was performed to examine the diagnostic use of OCTA in DR to date. Medline, EMBASE, and Cochrane databases were searched to find relevant studies. Sixty-one original studies were selected for the review. RESULTS AND DISCUSSION: OCTA has demonstrated the ability to identify microvascular features of DR such as microaneurysms, neovascularisation, and capillary non-perfusion. Furthermore, OCTA is enabling quantitative evaluation of the microvasculature of diabetic eyes. It has demonstrated the ability to detect early microvascular changes, in eyes with or without clinically evident DR. It has also been shown to detect progressive changes in the foveal avascular zone, and vascular perfusion density, with worsening severity of disease. It provides three-dimensional visualisation of the individual retinal vascular networks and is thereby enhancing our understanding of the role of the deeper vasculature in the pathogenesis of diabetic retinopathy and maculopathy. CONCLUSION: However, limitations exist with current OCTA technology, in respect to the small field of view, image quality, projection artefact, and inaccuracies in analysis of the deeper vascular layers. While questions remain regarding its practical applicability in its present form, with continuing development and improvement of the technology, the diagnostic value of OCTA in diabetic retinopathy is likely to become evident.
Authors: Talisa E de Carlo; Adam T Chin; Tony Joseph; Caroline R Baumal; Andre J Witkin; Jay S Duker; Nadia K Waheed Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2016-02 Impact factor: 1.300
Authors: Thomas S Hwang; Simon S Gao; Liang Liu; Andreas K Lauer; Steven T Bailey; Christina J Flaxel; David J Wilson; David Huang; Yali Jia Journal: JAMA Ophthalmol Date: 2016-04 Impact factor: 7.389
Authors: Sarwar Zahid; Rosa Dolz-Marco; K Bailey Freund; Chandrakumar Balaratnasingam; Kunal Dansingani; Fatimah Gilani; Nitish Mehta; Emma Young; Meredith R Klifto; Bora Chae; Lawrence A Yannuzzi; Joshua A Young Journal: Invest Ophthalmol Vis Sci Date: 2016-09-01 Impact factor: 4.799
Authors: Isaac Gendelman; A Yasin Alibhai; Eric M Moult; Emily S Levine; Phillip X Braun; Nihaal Mehta; Yi Zhao; Akihiro Ishibazawa; Osama A Sorour; Caroline R Baumal; Andre J Witkin; Elias Reichel; James G Fujimoto; Jay S Duker; Nadia K Waheed Journal: Int J Retina Vitreous Date: 2020-03-19